sub-header
Subscribe
Back to Results

FTC v. Endo Pharms., Inc.: The D.C. District Court “Treads [the] Tenuous Line Between Patent and Antitrust Laws” to Reject the FTC’s Challenge of an Exclusive License That Allegedly Discouraged Competition

| Stephen W. LarsonAdam Powell
Publication

Partners Stephen Larson and Adam Powell authored "FTC v. Endo Pharms., Inc.: The D.C. District Court 'Treads [the] Tenuous Line Between Patent and Antitrust Laws' to Reject the FTC’s Challenge of an Exclusive License That Allegedly Discouraged Competition," which was published in The AIPLA Antitrust News, a publication of the AIPLA Committee on Antitrust Law.

Read the full article here.

Stephen W. Larson - Partner
Stephen W. Larson
Stephen Larson has extensive experience litigating high-stakes cases in a wide variety of technology areas, including medical devices, biotechnology, software...
Adam Powell- Partner - San Diego
Adam Powell
Clients turn to Adam Powell to handle their most technically complex issues in the medical device, electronics, pharmaceuticals, and biotechnology industries...